logo
Why eating too much ginger, turmeric or cinnamon could interfere with your prescription medication

Why eating too much ginger, turmeric or cinnamon could interfere with your prescription medication

Yahoo09-05-2025

A sprinkle of cinnamon on your porridge, a pinch of turmeric in your curry, or a dash of ginger in your biscuits – these popular spices are kitchen staples around the world. For centuries, spices haven't just been used to flavour food but also valued in traditional Ayurvedic and Chinese medicine for their healing properties. But could something as innocent as a spoonful of spice interfere with your medication?
Take cinnamon, for example. Sourced from the bark of Cinnamomum trees, it contains active compounds like cinnamaldehyde, eugenol and coumarin. Cinnamon oil, derived from the bark or leaves, is often used in food flavouring, fragrances and herbal remedies.
Cinnamon has been linked to a range of potential health benefits: it's rich in antioxidants, it may reduce inflammation, it helps regulate blood sugar levels, it lowers the risk of heart disease, and even improves brain function. Traditionally, it's also been used to ease digestion and ward off infections.
But a recent study from the University of Mississippi has raised concerns that cinnamon could reduce the effectiveness of certain medications. In lab tests, cinnamaldehyde was found to activate receptors that speed up how drugs are cleared from the body – potentially making them less effective. While this research is still in the early stages and hasn't yet been tested in humans, it raises important questions about how cinnamon interacts with modern medicines.
The type of cinnamon matters too. The cinnamon commonly found in supermarkets – cassia cinnamon – is cheaper, widely available and comes from parts of Asia. Ceylon cinnamon, often labelled as 'true cinnamon,' originates from Sri Lanka and is generally more expensive. Cassia cinnamon contains higher levels of coumarin, a natural compound that can harm the liver in high doses, according to studies. Coumarin is also a known anticoagulant, meaning it helps prevent blood clots, which is useful in medicine but risky when combined with blood-thinning drugs like warfarin.
There have been a few case reports suggesting that cinnamon supplements could increase the risk of bleeding when taken with anticoagulants. This is probably due to coumarin affecting liver enzymes responsible for breaking down drugs like warfarin. Some research also suggests cinnamon could potentially interact with other medications, including painkillers, antidepressants, anti-cancer drugs and diabetes medications.
But before you throw out your spice rack, it's important to remember: the risks come from high doses, particularly in supplement form. A light sprinkle of cinnamon on your porridge is unlikely to cause problems.
Another spice with medicinal promise – and potential risks – is turmeric. Known for its vivid yellow colour and use in both cooking and traditional medicine, turmeric contains curcumin, a compound praised for its anti-inflammatory and antioxidant effects.
However, information on turmeric's interactions with medications is still limited. Most of what we know comes from lab and animal studies, which don't always translate directly to humans. Still, there's evidence that curcumin can affect how some drugs are metabolised, particularly by interfering with liver enzymes. This means it could potentially interact with antidepressants, blood pressure medications, chemotherapy drugs and certain antibiotics.
Turmeric also has natural blood thinning properties, which could amplify the effects of medications like warfarin or aspirin. Animal studies suggest turmeric may also lower blood sugar, meaning it could increase the effects of anti-diabetic drugs or insulin. Additionally, turmeric has been shown to reduce blood pressure, which, when combined with blood pressure medications, could cause an excessive drop.
As with cinnamon, these effects are most often linked to high dose supplements, not the small amounts used in food.
Ginger is another spice celebrated for its health benefits, particularly its anti-nausea and anti-inflammatory effects. But its active compounds, including gingerol, may also influence how your body handles medications.
Ginger can act as a mild blood thinner, which means combining it with anticoagulants could raise the risk of bleeding. The evidence is mixed when it comes to ginger and diabetes: while some studies suggest it may lower blood sugar, more research is needed to fully understand the effect it may have when taken alongside anti-diabetic medications.
While lab studies suggest these spices may affect how the body processes certain medications, the vast majority of these effects have been observed in high doses –usually from supplements, not everyday cooking.
If you're taking medications, especially blood thinners, diabetes medicines, or chemotherapy drugs, it's worth having a quick chat with your doctor or pharmacist before starting any new herbal supplements. But for most people, using spices in typical culinary amounts is safe – and a delicious way to add both flavour and potential health benefits to your meals.
So go ahead: sprinkle, pinch, or dash – just be mindful of what's in your medicine cabinet – and be wary of taking any herbal supplement in high does.
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Dipa Kamdar does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The Silent Virus Behind Mono Is Now a Prime Suspect in Major Diseases
The Silent Virus Behind Mono Is Now a Prime Suspect in Major Diseases

Bloomberg

timean hour ago

  • Bloomberg

The Silent Virus Behind Mono Is Now a Prime Suspect in Major Diseases

Jeff Cohen was 17 and living in Baltimore when mononucleosis knocked him off his feet. He thinks he got it from his high school girlfriend — now his wife — who once he got sick would ring the doorbell, drop off his homework and run away before he could get to the door. 'She was afraid I might give her something,' said Cohen, who was laid low for a week with a fever, sore throat and swollen glands. 'I'm certain it actually came from her.' That teenage case of mono, also known as glandular fever, would make a lasting impression. Five decades later, Cohen is now chief of the Laboratory of Infectious Diseases inside the National Institutes of Health, where he's leading efforts to create a vaccine for Epstein-Barr virus, or EBV, which causes mono.

Overpopulation Solution: Veterinarians donating time to help strays
Overpopulation Solution: Veterinarians donating time to help strays

Yahoo

timean hour ago

  • Yahoo

Overpopulation Solution: Veterinarians donating time to help strays

LEBANON — This year, an unprecedented number of stray cats have been flooding rescue facilities, calling for a viable and safe solution for these furry friends. The Lebanon Veterinary Hospital offered a solution by creating the SNIPS (Spays, Neuters Impact Populations) program, in which veterinarians are donating their time to provide spay and neuter services for rescue organizations at a small cost. According to Bernadette Orscher, VP of marketing for the network of hospitals Piper Veterinary, this crisis is the consequence of various factors. One of the factors is that for each unaltered female cat, 36 kittens can be born every year. Other factors have played a role in this crisis, like the increased costs for spay and neuter procedures going from $400 to over $1,000 in Connecticut. Economic pressure has also led to an increase in pet abandonments. 'That flywheel of unspayed and neutered animals is just going to continue to raise the number of pet abandonment numbers,' she said. 'The state now has officially recognized the overpopulation issue. So, instead of putting additional strains on town resources, we're trying to help and get ahead of it.' Although rescues get help through the State Voucher Program to finance these procedures, the number of animals in need have led many rescues to be out of vouchers before the year ended. With SNIPS, the Lebanon Veterinary Hospital is providing these procedures at a discounted rate, whether they still have these vouchers or not. In a few numbers, a dog spay cost over $800, which is reduced to $200 with the SNIPS program. For cats, the procedures start at $80. In addition to each surgery, the animals also get two vaccinations at no additional cost. 'The veterinary team is absorbing a significant amount of the cost to offer this to rescues,' she said. 'So, we're trying to make sure we can keep it as inclusive as possible and open as possible.' Throughout the summer, Piper Veterinary and the Lebanon Veterinary Hospital will be hosting programs to help animals get the medical attention they need to limit overpopulation. 'We're trying to maximize the number of animals that we're able to help and support. And that's best negotiated through rescue groups,' Orscher said. On June 9, they will have a clinic day with PAWS cat shelter and are still scheduling events to do throughout the summer. 'There's nothing harder in vet medicine than seeing discarded or unwanted pets,' said Dr. Steven Zickmann of Lebanon Veterinary Hospital. 'We have to do better, or it will never stop.'

Matter Neuroscience announces collaboration with Stanford Medicine combining Matter protocol with real-time fMRI neurofeedback to support emotion-based interventions in depression
Matter Neuroscience announces collaboration with Stanford Medicine combining Matter protocol with real-time fMRI neurofeedback to support emotion-based interventions in depression

Associated Press

timean hour ago

  • Associated Press

Matter Neuroscience announces collaboration with Stanford Medicine combining Matter protocol with real-time fMRI neurofeedback to support emotion-based interventions in depression

This collaboration sets out to explore whether using the Matter Neuroscience protocol combined with real-time neurofeedback can influence emotional brain networks relevant to depression. PALO ALTO, Calif., June 3, 2025 /PRNewswire/ -- Matter Neuroscience is pleased to announce a collaboration with Stanford Medicine's Psychiatry and Behavioral Sciences Department. The controlled, multi-arm study will enroll at least 210 depressed patients with the objective to significantly reduce clinical endpoints using real-time 7T fMRI neurofeedback in combination with the Matter protocol selectively activating key brain areas hosting distinct positive emotions. The clinical endpoints are paralleled with several molecular, emotional and behavioral biomarkers. If successful, the findings can be integrated into a full-scale clinical trial with the potential to inform future non-pharmaceutical curative therapies for depression. Professor Nolan Williams, M.D. an Associate Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab will serve as the Principal Investigator on the study. 'This study allows us to investigate how targeted emotion training, guided by real-time fMRI, may influence mood-related brain circuits,' said Dr. Williams. 'What makes this particularly interesting is the opportunity to evaluate both the neural mechanisms involved in emotion regulation and the feasibility of translating this approach into a deliverable treatment in the clinic or home one day.' Matter CEO Axel Bouchon shares, 'After we have seen positive effects in emotional wellbeing of healthy individuals in our studies in the past 4-5 years, it is just one of the most exciting studies I have witnessed in my career. Ultimately, we try to use the latest advancements in MRI technology and the patients' good memories as a personalized medicine to reduce, maybe permanently cure, their depressive symptoms.' About Matter Matter Neuroscience was founded in 2019 by Axel Bouchon and Ben Goldhirsh. Matter's mission is to use neuroscience to help people live longer, healthier, happier lives. Matter Neuroscience runs a consumer technology business ( ) and a medical business addressing healthy individuals and patients, respectively. Matter is led by CEO Axel Bouchon (Moderna, Bayer, ARCH Venture Partners.) Ben Goldhirsh (GOOD Worldwide and the Goldhirsh Foundation) serves as Matter's Chairman and Head of Product. Visit to learn more about Matter. Download the Matter app, named 'App of the Day' on Apple's App Store. Follow Matter on Instagram and Tiktok for education and inspiration for living a happier life. About the Matter Protocol Matter Neuroscience and its academic partners in Maastricht and Copenhagen have conducted several research studies successfully identifying a human map for distinct positive emotions in the brain. Using this map as a directional biomarker, a team led by Professor Rainer Goebel at the Maastricht Brain Imaging Center in the Netherlands developed a protocol that allows for training and intensifying distinct human emotions using real-time fMRI neurofeedback with autobiographical memories. View original content to download multimedia: SOURCE Matter Neuroscience

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store